<DOC>
	<DOCNO>NCT01556633</DOCNO>
	<brief_summary>This open-label , prospective , single dose study evaluate pharmacokinetics safety Tamiflu ( oseltamivir ) volunteer dialysis volunteer creatinine clearance 10 30 mL/min . Volunteers receive single oral dose Tamiflu .</brief_summary>
	<brief_title>A Single Dose Study Tamiflu Volunteers Dialysis And Volunteers With Reduced Creatinine Clearance</brief_title>
	<detailed_description />
	<mesh_term>Oseltamivir</mesh_term>
	<criteria>General Adult volunteer , age 19 90 year Medically stable hospitalization significant disease 3 month study start Volunteers dialysis A document wellestablished dialysis therapy Volunteers reduce creatinine clearance Creatinine clearance 10 30 mL/min Stable renal function Clinically significant unstable disease ( e.g. , cardiac , hepatic , pulmonary ) Medical history concurrent medical condition would compromise participation study Hypotensive episodes symptom fainting , dizziness lightheadedness 4 week screen Uncontrolled hypotension hypertension Infection hepatitis B , hepatitis C human immunodeficiency virus</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>